Inhibitory Effects of Panduratin A on Periodontitis-Induced Inflammation and Osteoclastogenesis through Inhibition of MAPK Pathways In Vitro
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Periodontitis is an inflammatory disease caused by microbial lipopolysaccharide (LPS), destroying gingival tissues and alveolar bone in the periodontium. In the present study, we evaluated the anti-inflammatory and anti-osteoclastic effects of panduratin A, a chalcone compound isolated from Boesenbergia pandurata, in human gingival fibroblast-1 (HGF-1) and RAW 264.7 cells. Treatment of panduratin A to LPS-stimulated HGF-1 significantly reduced the expression of interleukin-1β and nuclear factor-kappa B (NF-κB), subsequently leading to the inhibition of matrix metalloproteinase-2 (MMP-2) and MMP-8 compared with that in the LPS control (**p < 0.01). These anti-inflammatory responses were mediated by suppressing the mitogen-activated protein kinase (MAPK) signaling and activator protein-1 complex formation pathways. Moreover, receptor activator of NF-κB ligand (RANKL)-stimulated RAW 264.7 cells treated with panduratin A showed significant inhibition of osteoclastic transcription factors such as nuclear factor of activated T-cells c1 and c-Fos as well as osteoclastic enzymes such as tartrate-resistant acid phosphatase and cathepsin K compared with those in the RANKL control (**p < 0.01). Similar to HGF-1, panduratin A suppressed osteoclastogenesis by controlling MAPK signaling pathways. Taken together, these results suggest that panduratin A could be a potential candidate for development as a natural anti-periodontitis agent.
Abstract
Periodontitis is an inflammatory disease caused by microbial lipopolysaccharide (LPS), destroying gingival tissues and alveolar bone in the periodontium. In the present study, we evaluated the anti-inflammatory and anti-osteoclastic effects of panduratin A, a chalcone compound isolated from Boesenbergia pandurata, in human gingival fibroblast-1 (HGF-1) and RAW 264.7 cells. Treatment of panduratin A to LPS-stimulated HGF-1 significantly reduced the expression of interleukin-1β and nuclear factor-kappa B (NF-κB), subsequently leading to the inhibition of matrix metalloproteinase-2 (MMP-2) and MMP-8 compared with that in the LPS control (**p < 0.01). These anti-inflammatory responses were mediated by suppressing the mitogen-activated protein kinase (MAPK) signaling and activator protein-1 complex formation pathways. Moreover, receptor activator of NF-κB ligand (RANKL)-stimulated RAW 264.7 cells treated with panduratin A showed significant inhibition of osteoclastic transcription factors such as nuclear factor of activated T-cells c1 and c-Fos as well as osteoclastic enzymes such as tartrate-resistant acid phosphatase and cathepsin K compared with those in the RANKL control (**p < 0.01). Similar to HGF-1, panduratin A suppressed osteoclastogenesis by controlling MAPK signaling pathways. Taken together, these results suggest that panduratin A could be a potential candidate for development as a natural anti-periodontitis agent.
참고문헌 (26)
- Nibali L, "Tooth loss in aggressive periodontitis: a systematic review", J. Dent. Res., 92, pp.868~875 (2013)[DOI]
- Chapple ILC, "Diabetes and periodontal diseases: consensus report of the Joint EFP", AAP Workshop on Periodontitis and Systemic Diseases, 2013, pp.40, S106~S112
- Dietrich T, "The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease", J. Clin. Periodontol., 40, pp.S70~S84 (2013)
- Singhrao SK, "Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer's disease", Mediators Inflamm., 2015, pp.10~ (2015)
- Herath TD, "Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-<TEX>${\kappa}B$<", TEX> signal transduction cascade and immunoinflammatory response in human gingival fibroblasts, 2013, pp.8, e58496~
- Bartold PM, "Molecular and cell biology of healthy and diseased periodontal tissues", Periodontol. 2000, 40, pp.29~49 (2006)[DOI]
- Ko S Y, "Myricetin sup pesrses L PS-induced M MP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKLtreated RAW 264.7 cells", Arch. Oral Biol., 57, pp.1623~1632 (2012)
- Hienz SA, "Mechanisms of bone resorption in periodontitis", J. Immunol. Res., 2015, pp.615486~ (2015)
- He L, "Sinomenine down-regulates TLR4", TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis, 2016, pp.779, 66~79
- Wada T, "RANKL-RANK signaling in osteoclastogenesis and bone disease", Trends Mol. Med., 12, pp.17~25 (2006)[DOI]
- Asagiri M, "Autoamplification of NFATc1 expression determines its essential role in bone homeostasis", J. Exp. Med., 202, pp.1261~1269 (2005)[DOI]
- 김명석, "Effects of Orally Administered Fingerroot (Boesenbergia pandurata) Extract on Oxazolone-induced Atopic Dermatitis-like Skin Lesions in Hairless Mice", Food Science and Biotechnology, 22, pp.257~264 (2013), 한국식품과학회[DOI]
- Kyung-Min Park, "Antibacterial Activity of Panduratin A Isolated from Kaempferia pandurata against Porphyromonas gingivalis", Food Science and Biotechnology, 14(2), pp.286~289 (2005), 한국식품과학회
- Yanti, "Activity of panduratin A isolated from Kaempferia pandurata Roxb. against multi-species oral biofilms in vitro", J. Oral Sci., 51, pp.87~95 (2009)[DOI]
- Yanti, "Effects of panduratin A isolated from Kaempferia pandurata ROXB. on the expression of matrix metalloproteinase-9 by Porphyromonas gingivalis supernatant-induced KB cells", Biol. Pharm. Bull., 32, pp.110~115 (2009)[DOI]
- Shim JS, "Inhibitory effect of panduratin A on UV-induced activation of mitogenactivated protein kinases (MAPKs) in dermal fibroblast cells", Planta Med., 74, pp.1446~1450 (2008)[DOI]
- He Y, "Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways", Biochem. Biophys. Res. Commun., 449, pp.344~350 (2014)[DOI]
- Gomez-Florit M, "Quercitrin for periodontal regeneration: effects on human gingival fibroblasts and mesenchymal stem cells", Sci. Rep., 5, pp.16593~ (2015)[DOI]
- Maeso G, "Levels of metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis, and healthy gingiva", Quintessence Int., 38, pp.247~252 (2007)
- Rai B, "Levels of gingival crevicular metalloproteinases-8 and -9 in periodontitis", Saudi Dent. J., 22, pp.129~131 (2010)[DOI]
- Kida Y, "Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK", AP-1 and NF-kappaB in human gingival fibroblasts, 2005, pp.29, 159~168
- Yanti, "Inhibitory effect of panduratin A on c-Jun N-terminal kinase and activator protein-1 signaling involved in Porphyromonas gingivalis supernatant-stimulated matrix metalloproteinase-9 expression in human oral epidermoid cells", Biol. Pharm. Bull., 32, pp.1770~1775 (2009)[DOI]
- Baek JM, "Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos", nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone loss in mice, 2014, pp.19, 11628~11644
- Kim K, "MafB negatively regulates RANKL-mediated osteoclast differentiation", Blood, 109, pp.3253~3259 (2007)[DOI]
- Gutierrez-Venegas G, "Myricetin blocks lipoteichoic acid-induced COX-2 expression in human gingival fibroblasts", Cell. Mol. Biol. Lett., 19, pp.126~139 (2014)
- Xagorari A, "Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin", Br. J. Pharmacol., 136, pp.1058~1064 (2002)[DOI]